Hodgkin Lymphoma (Pediatric)
Malignant Lymphatic Neoplasm (Reed-Sternberg Cell Pathology)
Primary risk age: Adolescents (Rare under 5 years; peak incidence in the teenage years)
- Urgency
- Severe
- Typical age
- Adolescents (Rare under 5 years; peak incidence in the teenage years)
- Body system
- Oncological System
Typical course: Chemotherapy treatment typically spans 2 to 6 months depending on the stage; full physical recovery takes several months.
Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13
1. Summary & Pathophysiology
Malignant Lymphatic Neoplasm (Reed-Sternberg Cell Pathology)
Pathophysiology (Development Path)
Malignant clonal B-cells (Reed-Sternberg cells) arise in a lymph node. These cells secrete cytokines that recruit a massive, non-malignant inflammatory cell infiltrate (lymphocytes, macrophages, eosinophils), leading to painless enlargement of the lymph node and systemic symptoms.
Primary Causes & Etiology
Unknown etiology; associated with Epstein-Barr Virus (EBV) infection and genetic predisposition factors.
2. Symptom Continuum
- Early Onset Signs
Painless, firm, rubbery enlargement of a single lymph node group, most commonly in the cervical (neck) or supraclavicular area.
- Progressive Phase
The "B Symptoms": unexplained fevers ($>38^circ ext{C}$), night sweats (soaking the sheets), and unexplained weight loss ($>10%$ of body weight over 6 months). Pruritus (itching) can also occur.
- Severe Indicators
Mediastinal mass: a large tumor in the chest causing a persistent dry cough, shortness of breath, or superior vena cava syndrome (swelling of the face and neck). Splenomegaly and hepatomegaly.
3. Clinical Verification
Excisional lymph node biopsy showing the classic binucleated Reed-Sternberg cells ("owl-eye" appearance). Staging is performed using PET/CT scans and bone marrow biopsy.
4. Care & Elements Plan
Primary Care Treatment Plan
Risk-adapted chemotherapy protocols, often combined with low-dose involved-field radiation therapy. The goal is to maximize cure rates while minimizing long-term radiation toxicities.
Home Support Elements
Monitor for fever, especially during chemotherapy cycles. Ensure a high-calorie, nutritious diet to manage weight loss. Support psychological needs during adolescent cancer therapy.
Generic Active Ingredients (No Brands)
- Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD chemotherapy regimen active ingredients)
- Prednisone (steroid active ingredient).
Lists active elements only. Never administer self-designed therapies.
5. Doctor Critical Lines
Critical Thresholds: When to See a Doctor
Consult a doctor if your child has a swollen lymph node that is painless and does not shrink after 2-3 weeks, or if they develop unexplained night sweats, weight loss, or persistent fevers.
6. Vaccine & Prevention
Routine Prophylaxis (Prevention)
No preventative measures exist, as the primary trigger remains unclassified.
Immunization Context
Avoid live vaccines during and for 6-12 months after completing chemotherapy; maintain pneumococcal and influenza vaccines.
7. Timelines & Outlook
Active Timeline
Chemotherapy treatment typically spans 2 to 6 months depending on the stage; full physical recovery takes several months.
Expected Prognosis
Outstanding. The cure rate for pediatric and adolescent Hodgkin lymphoma exceeds 95% with modern staging and risk-directed therapy.
Potential Untreated Complications
Secondary malignancies (breast cancer, leukemia later in life), radiation-induced thyroid dysfunction, pulmonary fibrosis (from bleomycin), and cardiotoxicity.
